Limitations, agreements, and source contact

Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors · Source last updated 2024-03-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

michael_brady@urmc.rochester.edu

organization

University of Rochester

phone

585-276-3203

title

Michael Brady

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice